Shenzhen Kangtai Biological Products Co., Ltd. (SHE:300601)
China
· Delayed Price · Currency is CNY 14.05
-0.03 (-0.21%)
At close: Mar 9, 2026
SHE:300601 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 15,693 | 19,155 | 30,324 | 27,232 | 67,700 | 119,407 | Upgrade
|
| Market Cap Growth | -11.69% | -36.83% | 11.35% | -59.77% | -43.30% | 110.80% | Upgrade
|
| Enterprise Value | 15,913 | 20,961 | 31,692 | 28,013 | 65,942 | 118,173 | Upgrade
|
| Last Close Price | 14.05 | 17.04 | 26.67 | 30.79 | 59.31 | 104.74 | Upgrade
|
| PE Ratio | - | 94.99 | 35.21 | - | 53.59 | 175.81 | Upgrade
|
| Forward PE | 54.39 | 20.24 | 22.39 | 22.73 | 50.97 | 114.36 | Upgrade
|
| PS Ratio | 5.82 | 7.22 | 8.72 | 8.63 | 18.54 | 52.81 | Upgrade
|
| PB Ratio | 1.63 | 1.98 | 3.18 | 3.03 | 7.39 | 16.00 | Upgrade
|
| P/TBV Ratio | 1.72 | 2.08 | 3.33 | 3.16 | 7.68 | 16.66 | Upgrade
|
| P/FCF Ratio | 36.23 | 146.15 | 96.37 | - | - | - | Upgrade
|
| P/OCF Ratio | 21.51 | 31.75 | 29.35 | 49.90 | 40.97 | 271.47 | Upgrade
|
| EV/Sales Ratio | 5.90 | 7.91 | 9.11 | 8.87 | 18.06 | 52.26 | Upgrade
|
| EV/EBITDA Ratio | 84.60 | 47.57 | 32.35 | 68.98 | 38.68 | 152.49 | Upgrade
|
| EV/EBIT Ratio | - | 161.26 | 40.72 | 136.56 | 50.71 | 173.26 | Upgrade
|
| EV/FCF Ratio | 36.74 | 159.93 | 100.72 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.20 | 0.21 | 0.26 | 0.26 | 0.30 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 9.95 | 4.59 | 2.52 | 5.64 | 1.61 | 0.12 | Upgrade
|
| Debt / FCF Ratio | 4.32 | 15.44 | 7.83 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.02 | -0.06 | 0.07 | 0.03 | -0.17 | -0.39 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.17 | -1.32 | 0.72 | 0.74 | -0.90 | -3.80 | Upgrade
|
| Net Debt / FCF Ratio | 0.51 | -4.45 | 2.24 | -0.39 | 1.73 | 3.75 | Upgrade
|
| Asset Turnover | 0.19 | 0.18 | 0.24 | 0.23 | 0.31 | 0.33 | Upgrade
|
| Inventory Turnover | 1.21 | 0.90 | 0.87 | 0.87 | 1.54 | 0.74 | Upgrade
|
| Quick Ratio | 1.95 | 2.04 | 1.66 | 1.84 | 2.35 | 2.68 | Upgrade
|
| Current Ratio | 2.70 | 2.36 | 1.96 | 2.21 | 2.80 | 3.04 | Upgrade
|
| Return on Equity (ROE) | -1.04% | 2.10% | 9.30% | -1.46% | 15.19% | 13.29% | Upgrade
|
| Return on Assets (ROA) | -0.89% | 0.55% | 3.37% | 0.92% | 6.85% | 6.30% | Upgrade
|
| Return on Invested Capital (ROIC) | -2.17% | 1.34% | 7.30% | 2.43% | 18.79% | 17.08% | Upgrade
|
| Return on Capital Employed (ROCE) | -1.70% | 1.10% | 6.30% | 1.80% | 11.30% | 8.70% | Upgrade
|
| Earnings Yield | -0.64% | 1.05% | 2.84% | -0.49% | 1.87% | 0.57% | Upgrade
|
| FCF Yield | 2.76% | 0.68% | 1.04% | -2.81% | -1.31% | -0.66% | Upgrade
|
| Dividend Yield | 0.64% | 0.53% | 1.43% | - | 1.21% | 0.18% | Upgrade
|
| Payout Ratio | - | 127.26% | 27.54% | - | 17.45% | 30.53% | Upgrade
|
| Buyback Yield / Dilution | -6.03% | -0.15% | -1.15% | 0.43% | -3.23% | -5.34% | Upgrade
|
| Total Shareholder Return | -5.39% | 0.38% | 0.28% | 0.43% | -2.02% | -5.16% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.